Previous Article | Next Article ![]()
Infection and Immunity, October 2000, p. 5953-5959, Vol. 68, No. 10
Department of Microbiology, Columbia
University, New York, New York 100321;
Harbor-UCLA Research and Education Institute, Torrance,
California 905022; and Department of
Medicine, UCLA School of Medicine, Los Angeles, California
900243
Received 11 April 2000/Returned for modification 15 June
2000/Accepted 5 July 2000
The ability of Candida albicans to respond to diverse
environments is critical for its success as a pathogen. The
RIM101 pathway controls gene expression and the
yeast-to-hyphal transition in C. albicans in response to
changes in environmental pH in vitro. In this study, we found that the
RIM101 pathway is necessary in vivo for pathogenesis.
First, we show that
rim101 Candida albicans is a
human pathogen of significant medical importance. It can cause
life-threatening systemic infections in susceptible individuals, such
as those with suppressed immune systems (18). In fact,
C. albicans now ranks fourth on the list of most frequently
acquired nosocomial bloodstream infections (20).
Hematogenously disseminated C. albicans colonizes diverse
organs during infection (18). Several properties have been
identified that are likely to be required for successful dissemination
and to cause disease, including secretion of degradative enzymes and the ability to switch between the yeast and hyphal growth forms (3, 10, 17). The ability to undergo the yeast-to-hyphal transition appears to be critical for pathogenesis, as mutants unable
to form hyphae are less virulent in the hematogenously disseminated
mouse model (8, 14, 16). This transition is regulated by
signal transduction pathways that respond to environmental signals and
stimulate changes in gene expression. One environmental signal that
regulates the yeast-to-hyphal transition in vitro is extracellular pH.
The ability to respond to extracellular pH appears to be important in
vivo. For example, De Bernardis et al. have shown that mutants which
are unable to grow at a given pH in vitro are limited in their sites of
infection in vivo (5).
We identified two homologs of the RIM101 pathway in C. albicans, RIM101 and RIM8, also referred to
as PRR2 and PRR1, respectively (4, 21,
22). In Saccharomyces cerevisiae and Aspergillus nidulans, the zinc finger transcription factor Rim101p (PacCp) is
regulated by proteolytic processing in response to environmental pH
(15, 19). At alkaline pH, several proteins, including Rim8p (PalFp), stimulate the processing of Rim101p to the active form which
governs changes in gene expression (15, 19). In C. albicans, the RIM101 pathway regulates several alkaline
responses, including stimulation of alkaline response genes, repression
of acidic response genes, and stimulation of the yeast-to-hyphal
transition (4, 21, 22). However, the RIM101
pathway is not required for growth at either alkaline or acidic pH in
vitro. Because the RIM101 pathway plays an important role in
responding to the environment in vitro, we examined the requirement for
this pathway in pathogenesis. Here, we show that the RIM101
pathway is required for several host-pathogen interactions and thus
pathogenesis. Further, our use of a suppressor mutation has allowed us
to narrow the range of RIM101 pathway functions that are
required for pathogenesis.
Strains and plasmids.
The C. albicans strains
used in this study are derivatives of SC5314 and are described in Table
1. Our parent strain, BWP17, is a triply
marked auxotrophic strain which we used to generate the
rim101
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Candida albicans RIM101 pH Response
Pathway Is Required for Host-Pathogen Interactions
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
/rim101
and
rim8
/rim8
mutants have a
significant reduction in virulence using the mouse model of
hematogenously disseminated systemic candidiasis. Second, these mutants
show a marked reduction in kidney pathology. Third, the
rim101
/rim101
and
rim8
/rim8
mutants show defects
in the ability to damage endothelial cells in situ. Finally, we show
that an activated allele of RIM101, RIM101-405,
is a suppressor of the rim8
mutation in vivo
as it rescues the virulence, histological, and endothelial damage
defects of the rim8
/rim8
mutant. These results demonstrate that the RIM101 pathway
is required for C. albicans virulence in vivo and
that the function of Rim8p in pathogenesis is to activate Rim101p.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
/rim101
and
rim8
/rim8
mutants by PCR
directed gene knockout (4, 26). All strains were reverted to
prototrophy using plasmid pGEM-HIS1 (26) to create
His+ strains and plasmid pRS-ARG-URA-BN (see below) to
create Arg+ and Ura+ strains as described
below. A prototrophic revertant of our parent strain, BWP17
(26), was generated as follows. First, BWP17 was transformed
with NotI-digested pRS-ARG-URA-BN to generate an
Arg+ Ura+ strain. This strain was then
transformed with NruI-digested pGEM-HIS1 (26) to
generate the prototrophic strain DAY185. DAY44, DAY62, and DAY114 were
described previously (4). To generate the prototrophic rim101
/rim101
and
rim8
/rim8
strains, DAY5 and
DAY61 (4, 26) were transformed with NruI-digested pGEM-HIS1 to generate the prototrophic strains DAY25 and DAY117, respectively. To generate prototrophic
RIM101/rim101
and
RIM8/rim8
heterozygous strains, we made DAY2
and BWP35 (4, 26) prototrophic as follows. DAY2 was
transformed with NruI-digested pGEM-HIS1 to generate the
His+ derivative DAY176. DAY176 was then transformed with
NotI-digested pRS-ARG-URA-BN to generate the prototrophic
strain DAY203. BWP35 was transformed with NotI-digested
pRS-ARG-URA-BN to generate the Ura+ derivative DAY191.
DAY191 was then transformed with NruI-digested pGEM-HIS1 to
generate the prototrophic strain DAY205.
TABLE 1.
C. albicans strains used in this study
/rim8
mutant was
complemented as follows. First wild-type RIM8 was amplified
from genomic DNA in a PCR with primers RIM8
500 clone
(5'-gggtcgacCCATTGTCTGTGGTTCGCTCTACC) and seq3c-rim8 (5'-GTTCCTGGACAAATCGTCATCC) using standard reaction
conditions (26). This fragment was ligated into pGEMT
(Promega) to generate pGEMT-RIM8. pGEMT-RIM8 was digested with
SalI, and the RIM8-containing band was ligated
into SalI-digested pGEM-HIS1, generating pDDB88. pDDB88 was
digested with NruI and transformed into DAY61 (4) to generate DAY117.
pRS-ARG-URA-BN is a derivative of pRS-ARG-URA-BH (26).
pRS-ARG-URA-BH was digested with ClaI and religated with the
Cla-Not linker CGATGCGGCCGCAT. This linker
introduces a NotI site into the ClaI site,
generating pRS-ARG-URA-BN.
Media and growth conditions. C. albicans was routinely grown in YPD (2% Bacto Peptone, 1% yeast extract, 2% dextrose). Selection following transformation was done on synthetic medium containing 6.7% yeast nitrogen base with ammonium sulfate and without amino acids, 2% dextrose, and uridine at 80 µg/ml, except when selecting for URA3, and supplemented with the necessary auxotrophic requirements of the cells (1). Cell densities were determined by dilution and counting on a hemacytometer.
Virulence assays.
C. albicans strains were passaged
overnight at room temperature in YPD at least three times prior to
injection. Cells were harvested, washed, counted using a hemacytometer,
and resuspended at a density of 2 × 106/ml in sterile
phosphate-buffered saline (Irvine Scientific, Irvine, Calif.). BALB/c
mice (
23 g, male) (B and K Universal, Fremont, Calif.) were infected
through the lateral tail vein with 500 µl (106
organisms). Mouse survival was monitored at least twice daily, and
moribund mice were euthantized by cervical dislocation. Following injections, dilutions of the fungal suspension were plated on YPD to
ensure that similar numbers of viable cells had been injected into the
mice. We used C. albicans strain DAY25 to infect 9 mice; DAY44, -62, -106, -203, and -205 to infect 10 mice each; DAY185 and
-117 to infect 20 mice each; and DAY114 to infect 21 mice. Statistically significant differences between curves were determined using the Wilcoxon rank sum test. For these analyses, P
values of <0.05 were considered to be significant.
Fungal burden.
Fungal burdens were determined by injecting
106 C. albicans organisms into the tail veins of
23-g male BALB/c mice (Harlan). C. albicans were prepared
and injected as described above. At 20 and 40 h postinfection, the
kidneys and livers were removed aseptically from five mice per strain
per time point. The organs were weighed, homogenized, diluted in
sterile saline, and plated in Sabouraud dextrose agar (Difco). Colonies
were counted after incubation of the plates at 37°C for 24 to 48 h, and results were expressed as log CFU per gram of infected organ.
Histopathology. Concomitant with the fungal burden experiment, kidneys were removed aseptically from two mice per strain per time point. Kidneys were fixed for at least 4 h in 100% ethanol at room temperature. They were rinsed and stored in 10% buffered Formalin prior to embedding in paraffin. Thin sections were prepared and stained with hematoxylin and eosin, followed by Gomori methenamine silver, and examined by light microscopy. We found that using both stains allowed visualization of both C. albicans cells and neutrophils within the same section.
Endothelial damage.
Candida-stimulated endothelial
damage was measured using a chromium release assay described previously
(7). The inoculum size was 105 cells/well of a
24-well tissue culture plate. C. albicans and endothelial
cells were incubated together for 3 h. Specific release of
chromium was calculated using the formula [(2 × experimental release)
(2 × spontaneous release)]/[total
incorporation
(2 × spontaneous release)] as described
previously (7). All experiments were performed in triplicate
and repeated twice.
| |
RESULTS |
|---|
|
|
|---|
Virulence and the RIM101 pathway.
To determine if
the RIM101 pathway has a role in virulence, we analyzed the
effect of RIM101 pathway mutants in the hematogenously disseminated murine model. Wild-type and mutant strains were injected into mice via the tail vein, and survival of the mice was monitored (Fig. 1A to C). The wild-type and
heterozygous RIM101/rim101
strains (DAY185 and
DAY203) had similar degrees of virulence, with mice having a 3-day
median survival time (Fig. 1A). However, the homozygous
rim101
/rim101
strain (DAY25) had
markedly diminished virulence compared to the wild-type strain, with
mice having a 10-day median survival time (P < 0.0001). The complemented
rim101
/rim101
+RM101 strain
(DAY44) was as virulent as the wild type, demonstrating that the
virulence defect of the
rim101
/rim101
mutant is due to
loss of Rim101p. Thus, Rim101p is required for virulence in this animal
model.
|
/rim8
mutant (Fig. 1B). The heterozygous RIM8/rim8
strain (DAY205) maintained wild-type levels of virulence. However, the
rim8
/rim8
strain (DAY117) had
markedly diminished virulence, with mice having a 7-day median survival
time (P < 0.0001). We noted that the
rim8
/rim8
mutant was
significantly more virulent than the
rim101
/rim101
mutant
(P < 0.0005). Mice infected with the complemented
rim8
/rim8
+RIM8 strain (DAY106)
had a median survival time of 4.5 days, which was not statistically
separable from that of the wild type (P > 0.10). Thus,
the rim8
/rim8
mutant virulence
defect is due to loss of Rim8p. These results suggest that Rim8p is
required for virulence in this animal model. Because the complemented
rim8
/rim8
strain behaved
identically to the suppressed
rim8
/rim8
+RIM101-405 strain
(see below), we focused only on the suppressed strain.
To demonstrate that we had successfully infected mice with viable
C. albicans, we analyzed the fungal burdens in the livers and kidneys of the RIM101 pathway mutants (Table
2). The wild-type, rim101
/rim101
,
rim101
/rim101
+RIM101, and
rim8
/rim8
strain livers had
similar fungal burdens after both 20 and 40 h of infection. Thus,
the rim101
/rim101
and
rim8
/rim8
strains were able to
colonize the liver as well as the wild-type strain was during the first
40 h of infection. The kidneys of these strains had similar fungal
burdens 20 h postinfection as well. However, both the
rim101
/rim101
and
rim8
/rim8
mutants failed to show
the dramatic fungal burden increase seen 40 h postinfection in the
kidneys of mice infected with the wild-type strain and, to a lesser
extent, in those infected with the
rim101
/rim101
+RIM101 strain.
These results demonstrate that the
rim101
/rim101
and
rim8
/rim8
mutants were able to
colonize the kidneys as well as the wild type did during the first
20 h of infection. However, the
rim101
/rim101
and
rim8
/rim8
mutants grow less well
than the wild type in the kidneys during prolonged infection.
|
Histopathology.
Several features of a pathogenic infection are
observed in murine kidneys infected with C. albicans
(18). To determine whether the RIM101 pathway is
required for these responses, we removed kidneys infected with the
wild-type strain and RIM101 pathway mutants for histological
examination. Forty hours postinfection, three features of a successful
infection were seen in kidneys colonized with wild-type and
rim101
/rim101
+RIM101 cells.
First, most wild-type cells had germinated, forming long hyphae within
the kidney (Fig. 2B).
Second, wild-type cells elicited a strong host immune
response, as seen by the number of neutrophils surrounding the C. albicans organisms (Fig. 2A). Third, microabscesses, the sites of
concentrated C. albicans and neutrophils, were disseminated
throughout the kidney (Fig. 2A). The
rim101
/rim101
and
rim8
/rim8
strains showed defects
in these assays: there were few organisms, and those that were apparent
were often in the yeast form (Fig. 2D and H). Further, there was poor
stimulation of the immune response and there were few microabscesses
(Fig. 2C and G). Similar results were seen 20 h postinfection
(data not shown). We noted that the rim101
/rim101
mutant was more
defective than the rim8
/rim8
mutant by these three criteria (compare panels C and D with G and H in
Fig. 2). Thus, both Rim101p and Rim8p are required for host-pathogen
interactions leading to normal germination and the development of
lesions in the murine kidney.
|
Endothelial damage.
We analyzed the ability of
RIM101 pathway mutants to cause damage to endothelial cells
in situ. Filler et al. proposed that Candida-stimulated
endothelial damage occurs shortly after intravenous infection and is
important for entry into the underlying tissues (7). We
assayed endothelial cell damage by monitoring 51Cr release
into the medium from lysed endothelial cells in the presence and
absence of C. albicans (7). The wild-type,
RIM101/rim101
, and
rim101
/rim101
+RM101 strains
caused ~35% damage after 3 h of incubation with endothelial
cells and were not statistically significantly different from each
other (Fig. 3). The
rim101
/rim101
and
rim8
/rim8
strains caused 20 and
25% damage to endothelial cells, respectively, a significant reduction
compared to the wild type (P < 0.001). Further, the
rim101
/rim101
strain was more
defective than the rim8
/rim8
strain (P < 0.05). Endothelial cell damage requires
C. albicans germination (9), but we found that
all strains, including the rim101
/rim101
and
rim8
/rim8
mutants, germinated
equally well (data not shown). Since the RIM101 pathway
mutant germinated normally in this assay, these results suggest that
the damage defect is due to a downstream event, such as reduced
expression of proteases or other factors required for damage
(12). Thus, both Rim101p and Rim8p are required to
induce wild-type levels of damage to endothelial cells.
|
Suppression of virulence defects.
Suppression analysis is a
powerful tool with which to identify the cause of a mutant phenotype.
The RIM101-405 allele expresses a C-terminally truncated
Rim101p which should not require processing for activity and restores
filamentation to the rim8
/rim8
mutant in vitro (4). We used this allele to elucidate the nature of the rim8
/rim8
defect
in virulence by genetic suppression studies. First, the rim8
/rim8
+RIM101-405 strain was
more virulent than the rim8
/rim8
strain (P < 0.0001) and was statistically
indistinguishable from the wild-type strain or the complemented
rim8
/rim8
+RIM8 strain (Fig.
1C). Introduction of full-length RIM101 into the
rim8
/rim8
strain did not have
this effect, which demonstrated that this effect is an attribute of the
RIM101-405 mutation and not due to increased
RIM101 gene dosage. Although the RIM101-405
allele rescued the virulence defect, it did not rescue the fungal
burden defect of the rim8
/rim8
mutant in kidneys 40 h postinfection (Table 2).
/rim8
mutant phenotype by
histological examination. In kidneys 20 h postinfection, the
rim8
/rim8
+RIM101-405 strain
mimicked the rim8
/rim8
strain:
few cells had germinated, there was little immune response, and few
microabscesses were apparent (data not shown). Forty hours postinfection, the results mimicked the wild-type strain: many cells
had germinated to form hyphae (Fig. 2J), there was a pronounced immune
response, and microabscesses were apparent throughout the kidneys (Fig.
2I). Third, we looked for rescue in the endothelial damage assay (Fig.
3). The rim8
/rim8
+RIM101-405
strain caused 37% damage, a marked increase over the
rim8
/rim8
strain (P < 0.0001). Because the RIM101-405 allele, which
expresses a C-terminally truncated protein, rescues many phenotypes of
the rim8
/rim8
mutant, these
results argue that the function of Rim8p in virulence is to promote
activation of Rim101p.
| |
DISCUSSION |
|---|
|
|
|---|
Rim101p and Rim8p are required for host-pathogen
interactions based upon three assays. First,
rim101
/rim101
and
rim8
/rim8
mutants have a severe
virulence defect in a murine model. Second, by histological
examination, these mutants germinate poorly, fail to stimulate a strong
immune response, and fail to form microabscesses disseminated
throughout the kidney. Third, these mutants do not stimulate
endothelial cell damage to wild-type levels. Thus, the RIM101 pathway is required for the host-pathogen
interactions leading to virulence.
Previous in vitro studies of RIM101 pathway mutants did not
distinguish the rim101
/rim101
and rim8
/rim8
mutants (4,
21, 22). Here, we found that although both mutants were defective
for all host-pathogen interactions, they do show differences in the
three assays. First, the
rim8
/rim8
mutant is more
virulent than the rim101
/rim101
mutant. Second, the rim8
/rim8
mutant causes more hallmarks of pathology in kidneys than the rim101
/rim101
mutant. Third, the
rim8
/rim8
mutant stimulates more
endothelial cell damage than the
rim101
/rim101
mutant. Thus, we
found that both Rim8p and Rim101p are critical for responses in vitro
and in vivo but that the assays used in these studies are more
sensitive to perturbations of the RIM101 pathway.
Why is the rim101
/rim101
mutant
less virulent than the rim8
/rim8
mutant? Our genetic suppression analyses argue that the function of
Rim8p in vivo is to stimulate processing of Rim101p. Studies of both
A. nidulans and S. cerevisiae argue that, in the
rim8
/rim8
mutant, only
unprocessed Rim101p is present (15, 19). However, in the
rim101
/rim101
mutant, no Rim101p
is present. Thus, one simple model to explain the difference in
virulence is that both unprocessed and processed Rim101p function
during infection. The rim8
/rim8
mutant has a virulence defect because of the absence of processed Rim101p. The rim101
/rim101
mutant has a more severe phenotype due to the absence of both processed
and unprocessed Rim101p. We predict that molecular analysis of Rim101p
(PacC) pathways in C. albicans and other fungi will support
this new hypothesis that unprocessed Rim101p has a functional role in
target gene regulation.
In kidneys 20 and 40 h postinfection, the
rim8
/rim8
and
rim8
/rim8
+RIM101-405 strains
produced similar fungal burdens. However, these strains varied markedly
in their virulence. Similar results were reported for other mutants,
including the hwp1
/hwp1
and
chs3
/chs3
mutants (2, 13,
25). These results indicate that the fungal burden does not
necessarily predict the virulence phenotype. However, these results do
suggest that the RIM101 pathway is not required for
colonization of the kidney but is required for maintenance of infection.
We did find a strong correlation among the damage, histological, and virulence results. In fact, the histological and damage results appear to predict the virulence result of RIM101 pathway mutants. Similar results are seen for mutations affecting HWP1 and SAP2 (11, 12, 24, 25). Thus, we found that the histological and damage phenotypes are good predictors of the virulence phenotype.
One useful finding to come from these studies is that our wild-type strain appears to maintain normal virulence. We had previously created a triply marked auxotrophic strain to allow for rapid PCR-directed gene knockouts (two markers) and complementation (one marker). Here, we have analyzed host interactions with a prototrophic derivative of BWP17, DAY185. Mice infected with DAY185 appear to have survival times similar to those of mice infected with SC5314 and a related strain, CAI12 (23, 25). DAY185 stimulates endothelial damage to levels similar to those reported for SC5314 (12). Further, DAY185 grows well in kidneys and elicits a strong immune response. Thus, the BWP17 strain is useful to generate mutants rapidly and for consequent in vivo analyses as well.
What is the function of the RIM101 pathway in pathogenesis?
Our results argue that the RIM101 pathway is not simply
required for growth in vivo. We see that RIM101 pathway
mutants have a defect in fungal burden compared to the wild type.
However, if we compare the
rim8
/rim8
and
rim8
/rim8
+RIM101-405 mutants,
which produce similar fungal burdens, we find that the
rim8
/rim8
+RIM101-405 strain
behaves like the wild type in the other assays. Thus, a defect in
growth is not sufficient to explain the role of the RIM101
pathway in pathogenesis. The
rim8
/rim8
+RIM101-405 strain has
an activity lacking in the
rim8
/rim8
strain. We suggest
that stimulation of host cell damage may be a candidate for this
activity. Filler et al. have suggested that endothelial cell damage may
be required to stimulate expression of cytokines and leukocyte adhesion
molecules (6). If similar events occur in the kidney, then
we predict that mutants that inflict less cell damage would elicit a
weaker immune response. This is exactly what we see. Thus, we propose
that one function of the RIM101 pathway in pathogenesis is
to regulate the expression of genes that stimulate host cell damage.
| |
ACKNOWLEDGMENTS |
|---|
We thank the nurses at Harbor-UCLA Medical Center for collecting umbilical cords; Quynh-Trang Phan and Angela Sanchez for preparing endothelial cells; S. French for help with the histology; H. K. Lee, S. Klein, and D. Shepard for technical support; and Jim Ericson for help with photography of the histological sections. We are indebted to T. Lamb and H. Shuman for helpful criticism of the manuscript and to Scott Filler for numerous helpful and stimulating discussions. D.D. thanks Debra and Fia McWilliam for continued support throughout the course of this work.
This research was supported by a Mycology Scholar Award from the Burroughs Wellcome Fund to A.P.M. and by Public Health Service grants PO1AI-37194 and RO1AI-19990. A.S.I. is supported by a grant-in-aid from the American Heart Association, Western States Affiliate 9960030Y.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology, Columbia University, 701 W. 168th St. HHSC Room 918, New York, NY 10032. Phone: (212) 305-1554. Fax: (212) 305-1741. E-mail: dd251{at}columbia.edu.
Editor: V. J. DiRita
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Adams, A., D. E. Gotschling, C. A. Kaiser, and T. Stearns. 1997. Methods in yeast genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 2. |
Bulawa, C. E.,
D. W. Miller,
L. K. Henry, and J. M. Becker.
1995.
Attenuated virulence of chitin-deficient mutants of Candida albicans.
Proc. Natl. Acad. Sci. USA
92:10570-10574 |
| 3. | Cutler, J. E. 1991. Putative virulence factors of Candida albicans. Annu. Rev. Microbiol. 45:187-218[CrossRef][Medline]. |
| 4. |
Davis, D.,
R. B. Wilson, and A. P. Mitchell.
2000.
RIM101-dependent and -independent pathways govern pH responses in Candida albicans.
Mol. Cell. Biol.
20:971-978 |
| 5. |
De Bernardis, F.,
F. A. Mühlchlegel,
A. Cassone, and W. A. Fonzi.
1998.
The pH of the host niche controls gene expression in and virulence of Candida albicans.
Infect. Immun.
66:3317-3325 |
| 6. | Filler, S. G., A. S. Pfunder, B. J. Spellberg, J. P. Spellberg, and J. E. Edwards, Jr. 1996. Candida albicans stimulates cytokine production and leukocyte adhesion molecule expression by endothelial cells. Infect. Immun. 64:2609-2617[Abstract]. |
| 7. | Filler, S. G., J. N. Swedloff, C. Hobbs, and P. M. Luckett. 1995. Penetration and damage of endothelial cells by Candida albicans. Infect. Immun. 63:976-983[Abstract]. |
| 8. |
Gale, C. A.,
C. M. Bendel,
M. McClellan,
M. Hauser,
J. M. Becker,
J. Berman, and M. K. Hostetter.
1998.
Linkage of adhesion, filamentous growth, and virulence in Candida albicans to a single gene, INT1.
Science
279:1355-1358 |
| 9. |
Ghannoum, M. A.,
S. G. Filler,
A. S. Ibrahim,
Y. Fu, and J. E. Edwards, Jr.
1992.
Modulation of interactions of Candida albicans and endothelial cells by fluconazole and amphotericin B.
Antimicrob. Agents Chemother.
36:2239-2244 |
| 10. |
Ghannoum, M. A.
2000.
Potential role of phospholipases in virulence and fungal pathogenesis.
Clin. Microbiol. Rev.
13:122-143 |
| 11. | Hube, B., D. Sanglard, F. C. Odds, D. Hess, M. Monod, W. Schäfer, A. J. P. Brown, and N. A. R. Gow. 1997. Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence. Infect. Immun. 65:3529-3538[Abstract]. |
| 12. |
Ibrahim, A. S.,
S. G. Filler,
D. Sanglard,
J. E. Edwards, Jr., and B. Hube.
1998.
Secreted aspartyl proteinases and interactions of Candida albicans with human endothelial cells.
Infect. Immun.
66:3003-3005 |
| 13. |
Kohler, J. R., and G. R. Fink.
1996.
Candida albicans strains heterozygous and homozygous for mutations in mitogen-activated protein kinase signaling components have defects in hyphal development.
Proc. Natl. Acad. Sci. USA
93:13223-13228 |
| 14. | Leberer, E., K. Ziegelbauer, A. Schmidt, D. Harcus, D. Dignard, J. Ash, L. Johnson, and D. Y. Thomas. 1997. Virulence and hyphal formation of Candida albicans require the Ste20-like protein kinase CaCla4p. Curr. Biol. 7:539-546[CrossRef][Medline]. |
| 15. | Li, W., and A. P. Mitchell. 1997. Proteolytic activation of Rim1p, a positive regulator of yeast sporulation and invasive growth. Genetics 145:63-73[Abstract]. |
| 16. | Lo, H. J., J. R. Kohler, B. DiDomenico, D. Loebenberg, A. Cacciapuoti, and G. R. Fink. 1997. Nonfilamentous C. albicans mutants are avirulent. Cell 90:939-949[CrossRef][Medline]. |
| 17. | Mitchell, A. P. 1998. Dimorphism and virulence in Candida albicans. Curr. Opin. Microbiol. 1:687-692[CrossRef][Medline]. |
| 18. | Odds, F. C. 1988. Candida and candidosis, 2nd ed. Bailiere Tindall, London, England. |
| 19. |
Orejas, M.,
E. A. Espeso,
J. Tilburn,
S. Sarkar,
H. N. Arnst, and M. A. Penalva.
1995.
Activation of the Aspergillus PacC transcription factor in response to alkaline pH requires proteolysis of the carboxy-terminal moiety.
Genes Dev.
9:1622-1632 |
| 20. | Pfaller, M. A., R. N. Jones, S. A. Messer, M. B. Edmond, and R. P. Wenzel. 1998. National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility inthe SCOPE Program. Diagn. Microbiol. Infect. Dis. 31:327-332[CrossRef][Medline]. |
| 21. |
Porta, A.,
A. M. Ramon, and W. A. Fonzi.
1999.
PRR1, a homolog of Aspergillus nidulans palF, controls pH-dependent gene expression and filamentation in Candida albicans.
J. Bacteriol.
181:7516-7523 |
| 22. |
Ramon, A. M.,
A. Porta, and W. A. Fonzi.
1999.
Effect of environmental pH on morphological development of Candida albicans is mediated via the PacC-related transcription factor encoded by PRR2.
J. Bacteriol.
181:7524-7530 |
| 23. |
Rieg, G.,
Y. Fu,
A. S. Ibrahim,
X. Zhou,
S. G. Filler, and J. E. Edwards, Jr.
1999.
Unanticipated heterogeneity in growth rate and virulence among Candida albicans AAF1 null mutants.
Infect. Immun.
67:3193-3198 |
| 24. |
Sharkey, L. L.,
M. D. McNemar,
S. M. Saporito-Irwin,
P. S. Sypherd, and W. A. Fonzi.
1999.
HWP1 functions in the morphological development of Candida albicans downstream of EFG1, TUP1, and RBF1.
J. Bacteriol.
181:5273-5279 |
| 25. |
Tsuchimori, N.,
L. L. Sharkey,
W. A. Fonzi,
S. W. French,
J. E. Edwards, Jr., and S. G. Filler.
2000.
Reduced virulence of HWP1-deficient mutants of Candida albicans and their interactions with host cells.
Infect. Immun.
68:1997-2002 |
| 26. |
Wilson, R. B.,
D. Davis, and A. P. Mitchell.
1999.
Rapid hypothesis testing in Candida albicans through gene disruption with short homology regions.
J. Bacteriol.
181:1868-1874 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|